Early Clinical Experience with Ranibizumab for Occult and Minimally Classic Neovascular Membranes in Age-Related Macular Degeneration

Publisher： Karger

E-ISSN： 1423-0267|222|5|321-323

ISSN： 0030-3755

Source： Ophthalmologica, Vol.222, Iss.5, 2008-07, pp. : 321-323

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bimonthly Ranibizumab for Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 231, Iss. 2, 2013-12 ,pp. : 80-85

Karger

Access to resources Recommend Favorite

Review of Ranibizumab Trials for Neovascular Age-Related Macular Degeneration

By Patel Ravi D.   Momi Rominder S.   Hariprasad Seenu M.  

Seminars in Ophthalmology, Vol. 26, Iss. 6, 2011-11 ,pp. : 372-379

Informa Healthcare

Access to resources Recommend Favorite

Switch from Intravitreal Ranibizumab to Bevacizumab for the Treatment of Neovascular Age-Related Macular Degeneration: Clinical Comparison

By  

Ophthalmologica, Vol. 232, Iss. 3, 2014-08 ,pp. : 149-155

Karger

Access to resources Recommend Favorite

Transpupillary thermotherapy of occult CNV with no or minimally classic CNV in age-related macular degeneration

By Algvere Peep V.   Libert Carina   Seregard Stefan  

Seminars in Ophthalmology, Vol. 16, Iss. 2, 2001-06 ,pp. : 90-96

Informa Healthcare

Access to resources Recommend Favorite

Visual acuity and its decrease in classic neovascular age-related macular degeneration

By Behrendt Carolyn  

Ophthalmic Epidemiology, Vol. 11, Iss. 5, 2004-12 ,pp. : 359-367

Informa Healthcare

Access to resources Recommend Favorite